Table 2 Frequency of identified panel of markers in lobular carcinoma and controls [9]
Gene/Marker | Cancer | Controls |
|---|---|---|
BRCA1 | 0.7% (1/140) | 0% (0/140) |
CHEK2 | 19.4% (27/139) | 4.3% (6/140) |
p53 | 10.7% (12/112) | 6% (8/134) |
BRCA2 | 9% (9/100) | 4.8% (9/126) |
FGFR - nAA | 75.8% (69/91) | 60% (72/120) |
TNR | 72.7% (16/22) | 39.6% (19/48) |
NOD2 | 16.7% (1/6) | 0% (0/29) |
M3K - nAA | 80% (4/5) | 41.4% (12/29) |
Any marker | 99.30% (139/140) | 87.90% (123/140) |
Statistic | P = 0.00073 | |